Linked Life Data

10944130

Source:http://linkedlifedata.com/resource/pubmed/id/10944130

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
16
pubmed:dateCreated
2000-9-14
pubmed:abstractText
A randomized phase III trial was conducted to determine whether combination therapy with 13-cis-retinoic acid (13-CRA) plus interferon alfa-2a (IFNalpha2a) is superior to IFNalpha2a alone in patients with advanced renal cell carcinoma (RCC).
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2972-80
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:10944130-Administration, Oral, pubmed-meshheading:10944130-Adult, pubmed-meshheading:10944130-Aged, pubmed-meshheading:10944130-Aged, 80 and over, pubmed-meshheading:10944130-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:10944130-Carcinoma, Renal Cell, pubmed-meshheading:10944130-Disease-Free Survival, pubmed-meshheading:10944130-Female, pubmed-meshheading:10944130-Humans, pubmed-meshheading:10944130-Injections, Subcutaneous, pubmed-meshheading:10944130-Interferon-alpha, pubmed-meshheading:10944130-Isotretinoin, pubmed-meshheading:10944130-Kidney Neoplasms, pubmed-meshheading:10944130-Male, pubmed-meshheading:10944130-Middle Aged, pubmed-meshheading:10944130-Models, Statistical, pubmed-meshheading:10944130-Multivariate Analysis, pubmed-meshheading:10944130-Quality of Life, pubmed-meshheading:10944130-Questionnaires, pubmed-meshheading:10944130-Recombinant Proteins, pubmed-meshheading:10944130-Statistics, Nonparametric, pubmed-meshheading:10944130-Survival Analysis, pubmed-meshheading:10944130-Treatment Outcome
pubmed:year
2000
pubmed:articleTitle
Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma.
pubmed:affiliation
Genitourinary Oncology Service, Division of Solid Tumor Oncology, and the Departments of Medical Imaging and Biostatistics and Epidemiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III